Mix Contrast for COVID-19 Mild-to-Critical Prediction
Objective:
In a few patients with mild COVID-19, there is a possibility of the infection becoming severe or critical in the future. This work aims to identify high-risk patients who have a high probability of changing from mild to critical COVID-19 (only account for 5% of cases).
Methods:
Using traditional convolutional neural networks for classification may not be suitable to identify this 5% of high risk patients from an entire dataset due to the highly imbalanced label distribution. To address this problem, we propose a Mix Contrast model, which matches original features with mixed features for contrastive learning. Three modules are proposed for training the model: 1) a cumulative learning strategy for synthesizing the mixed feature; 2) a commutative feature combination module for learning the commutative law of feature concatenation; 3) a united pairwise loss assigning adaptive weights for sample pairs with different class anchors based on their current optimization status.
Results:
We collect a multi-center computed tomography dataset including 918 confirmed COVID-19 patients from four hospitals and evaluate the proposed method on both the COVID-19 mild-to-critical prediction and COVID-19 diagnosis tasks. For mild-to-critical prediction, the experimental results show a recall of 0.80 and a specificity of 0.815. For diagnosis, the model shows comparable results with deep neural networks using a large dataset. Our method demonstrates improvements when the amount of training data is small or imbalanced.
Significance:
Identifying mild-to-critical COVID-19 patients is important for early prevention and personalized treatment planning.
Insights
This study identifies patients at high risk of severe COVID-19 using a novel Mix Contrast model. The AI approach improves prediction accuracy for critical cases, aiding early intervention.
Area of Science:
- Artificial Intelligence
- Medical Imaging
- Infectious Diseases
Background:
- A small percentage of mild COVID-19 cases can progress to severe or critical illness.
- Accurate identification of these high-risk patients is crucial for timely intervention and personalized treatment.
Purpose of the Study:
- To develop a robust method for identifying patients with mild COVID-19 who are at high risk of future severe or critical illness.
- To address the challenge of imbalanced data in predicting rare but critical outcomes.
Main Methods:
- Proposed a Mix Contrast model for contrastive learning to handle imbalanced datasets.
- Introduced three novel modules: cumulative learning for mixed features, commutative feature combination, and united pairwise loss with adaptive weights.
- Evaluated the model on a multi-center computed tomography (CT) dataset of 918 COVID-19 patients.
Main Results:
- Achieved a recall of 0.80 and a specificity of 0.815 for mild-to-critical COVID-19 prediction.
- Demonstrated comparable performance to deep neural networks for COVID-19 diagnosis.
- Showcased improved performance with small or imbalanced training data.
Conclusions:
- The Mix Contrast model effectively identifies high-risk COVID-19 patients from mild cases.
- This AI-driven approach offers significant improvements for imbalanced classification tasks in medical prediction.
- Early identification facilitates personalized treatment strategies and improves patient outcomes.
More Related Videos
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Acute Coronary Syndrome III: Diagnostic Studies
Multiple Comparison Tests
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Hazard Ratio
For example, in a clinical trial...


